FDA Inspection
Danville Regional Medical CenterDanville Regional Medical Center – FDA Inspection, Apr 25, 2019
Record Details
This FDA Inspection record concerns Danville Regional Medical Center, with an inspection on April 25, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f160ffce-1ce4-40bc-a297-4010e2363786
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1090102
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 630.10(f)(6)(ii)Physical Assessment Determination - Skin Examination
- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Danville Regional Medical Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Danville Regional Medical Center
- FDA Inspection 1246222 - 2024-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.